[1] Iqbal U, Chaudhary A, Karim MA, et al. Association of Autoimmune Hepatitis and Celiac Disease: Role of gluten-free diet in reversing liver dysfunction. J Investig Med High Impact Case Rep,2017, 5: 2324709617705679.
[2] Evans KE, Sanders DS. Celiac disease . Gastroenterol Clin North Am,2012, 41: 639-650.
[3] Nadhem ON, Azeez G, Smalligan RD, et al. Review and practice guidelines for celiac disease in 2014. Postgrad Med,2015, 127: 259-265.
[4] Cukrowska B, Sowinska A, Bierla JB, et al. Intestinal epithelium, intraepithelial lymphocytes and the gut microbiota-Key players in the pathogenesis of celiac disease. World J Gastroenterol,2017, 23: 7505-7518.
[5] Dahlbom I, Nyberg BI, Berntson L, et al. Simultaneous detection of IgA and IgG antibodies against tissue transglutaminase: The preferred pre-biopsy test in childhood celiac disease. Scand J Clin Lab Invest,2016, 76: 208-216.
[6] Gujral N, Freeman HJ, Thomson AB. Celiac disease: prevalence, diagnosis, pathogenesis and treatment. World J Gastroenterol,2012, 18: 6036-6059.
[7] Husby S, Koletzko S, Korponay-Szabo IR, et al. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr,2012, 54: 136-160.
[8] Mounajjed T, Oxentenko A, Shmidt E, et al. The liver in celiac disease: clinical manifestations, histologic features, and response to gluten-free diet in 30 patients. Am J Clin Pathol,2011, 136: 128-137.
[9] Hoffmanova I, Sanchez D, Tuckova L, et al. Celiac disease and liver disorders: from putative pathogenesis to clinical implications. Nutrients,2018, 10(7): 892.
[10] Villavicencio Kim J, Wu GY. Celiac disease and elevated liver enzymes: a review. J Clin Transl Hepatol,2021, 9: 116-124.
[11] Rubio-Tapia A, Murray JA. Liver involvement in celiac disease. Minerva Med,2008, 99: 595-604.
[12] Singh P, Arora A, Strand TA, et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol,2018, 16: 823-836, e822.
[13] Abdo A, Meddings J, Swain M. Liver abnormalities in celiac disease. Clin Gastroenterol Hepatol,2004, 2: 107-112.
[14] Marciano F, Savoia M, Vajro P. Celiac disease-related hepatic injury: insights into associated conditions and underlying pathomechanisms. Dig Liver Dis,2016, 48: 112-119.
[15] Zali MR, Rostami Nejad M, Rostami K, et al. Liver complications in celiac disease. Hepat Mon,2011, 11: 333-341.
[16] Vajro P, Paolella G, Maggiore G, et al. Pediatric celiac disease, cryptogenic hypertransaminasemia, and autoimmune hepatitis. J Pediatr Gastroenterol Nutr,2013, 56: 663-670.
[17] Lammers KM, Lu R, Brownley J, et al. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology,2008, 135: 194-204, e193.
[18] Reilly NR, Lebwohl B, Hultcrantz R, et al. Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease. J Hepatol,2015, 62: 1405-1411.
[19] Miele L, Valenza V, La Torre G, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology,2009, 49: 1877-1887.
[20] Valvano M, Longo S, Stefanelli G, et al. Celiac disease, gluten-free diet, and metabolic and liver disorders. Nutrients,2020, 12(4): 940.
[21] Narciso-Schiavon JL, Schiavon LL. To screen or not to screen? Celiac antibodies in liver diseases. World J Gastroenterol,2017, 23: 776-791.
[22] Eslam M, Sanyal AJ, George J, et al. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology,2020, 158: 1999-2014, e1991. |
